Roche's Genentech, GSK, J&J and Amgen are among the biopharmas creating Amazon Alexa skills. (Credit: Shutterstock)

Speak­ing of the fu­ture: Ama­zon Alexa and the voice-en­abled app mar­ket for phar­ma and health­care

Wor­ried about that cough or won­der­ing what dif­fer­ent med­ica­tions can be tak­en at the same time? Just ask Alexa. That’s what more and more peo­ple are do­ing as voice as­sis­tant up­take con­tin­ues with health­care use es­pe­cial­ly on the rise.

Voice as­sis­tants for health­care jumped from just 7.5% of US adults us­ing them two years ago to 21% in 2021, ac­cord­ing to re­cent Voice­bot re­search, and shakes out to more than 54 mil­lion peo­ple. The boost was like­ly aid­ed by the Covid-19 pan­dem­ic when con­sumers turned to Ama­zon Alexa and Google As­sis­tant for an­swers at home – while at the same time, health and phar­ma com­pa­nies were rolling out new voice so­lu­tions ad­vanc­ing AI ini­tia­tives. Ama­zon’s Alexa voice as­sis­tant and Echo is by far the lead­ing plat­form in 70% of homes that use smart speak­ers.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.